Soticlestat
takeda
['takeda']
$ovid long-term safety &amp; efficacy findings from soticlestat open label extension study presented by takeda at american academy of neurology annual meeting 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i